The Effect of Pranayama Breathing Technique on Asthma Control, Pulmonary Function and Quality of Life

Last updated: September 28, 2019
Sponsor: TC Erciyes University
Overall Status: Completed

Phase

N/A

Condition

Asthma

Treatment

N/A

Clinical Study ID

NCT04110951
TDK-2017-7652
  • Ages > 18
  • All Genders

Study Summary

Most of the asthma patients prefer complementary and integrative applications as they continue to experience asthma symptoms despite pharmacological treatment. Pranayama, one of these treatments, is a breathing-based technique and is a part of yoga, an ancient Indian science. This study was carried out as randomized controlled single blind study in order to analyze the effect of pranayama breathing technique applied to individuals suffering from asthma on asthma control, pulmonary functions and quality of life. The study comprised 50 patients in total, as 25 patients in pranayama group and 25 patients in control group. The approval of ethics committee, permissions from the institutions, and informed voluntary approval of the individuals were obtained to conduct the research. The data of the research were collected through the application of Asthma Control Test (ACT), Asthma Quality of Life Questionnaire (AQLQ), pulmonary function test (PFT), and patient observation chart. Pranayama breathing technique was applied to pranayama group 20 minutes once a day for four weeks, and relaxation technique was applied to relaxation group similarly in addition to standard treatment. ACT, AQLQ, and PFT were evaluated twice as before and after the one month of application process. Meanwhile, the patients' PEF measurements were followed with individual PEF meter on daily basis. The value of p<0.05 was accepted statistically significant in the data analyses.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Can communicate,

  • To have an increase of %12 or 200 ml in FEV1 value after inhaler bronchodilator atbreathing function test,

  • To have chronic asthma diagnose with 6 months approved by doctors and receivingtreatment,

  • Asthma controls are not under control or partly under control in relation to GINA (Global Initiative for Asthma) values,

  • Taking beta2-agonist and/or ICS twice a week or more to control asthma symptoms,

  • There is not any chance in inhaler bronchodilator drug potions during the last fourweeks,

  • Can use a smart phone.

Exclusion

Exclusion Criteria:

  • To have lung diseases such as COPD,

  • To have tuberculosis and respiratory infection,

  • To have diabetes and coronary artery disease,

  • Smokers

  • Pregnant or nursing mother,

  • Doing regular exercise,

  • Benefitng from other complementary and integrative health applications duringtreatments

Study Design

Total Participants: 50
Study Start date:
February 01, 2018
Estimated Completion Date:
May 17, 2019

Connect with a study center

  • Nevşehir Haci Bektaş Veli Üniversitesi

    Nevşehir, Nerkez 50000
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.